• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Fast and highly selective determination of hemagglutinin content in quadrivalent influenza vaccine by reversed-phase high-performance liquid chromatog

tetano

Editor, Senior Moderator
J Chromatogr A. 2017 Oct 18. pii: S0021-9673(17)31528-5. doi: 10.1016/j.chroma.2017.10.041. [Epub ahead of print]
[h=1]Fast and highly selective determination of hemagglutinin content in quadrivalent influenza vaccine by reversed-phase high-performance liquid chromatography method.[/h] Lorbetskie B[SUP]1[/SUP], Fortin N[SUP]2[/SUP], Durno L[SUP]3[/SUP], Wang J[SUP]4[/SUP], Li C[SUP]5[/SUP], Li X[SUP]6[/SUP], Girard M[SUP]7[/SUP], Sauv? S[SUP]8[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Seasonal inactivated quadrivalent influenza vaccines are currently formulated to include antigens from two strains of influenza A and a strain from each of the two circulating influenza B virus lineages. However, the applicability of the potency assay currently required for the release of vaccines has been hindered due to cross-reactivity between the two B strains. In this study, a reversed-phase high-performance liquid chromatography method previously developed for the separation and quantitative determination of the hemagglutinin content in trivalent influenza vaccine preparations was further extended and found to be adaptable for the assessment of all four hemagglutinin antigens present in quadrivalent influenza vaccines. Vaccines prepared from monovalent bulks and commercial quadrivalent products from the past three vaccination seasons in the Northern Hemisphere were tested with the new method. The results showed excellent resolution of all four hemagglutinins from frequently interfering formulation agents such as surfactants. This method provides a simple approach for fast evaluation of quality and hemagglutinin strain identification in influenza vaccines. It is also the only physicochemical method capable of distinguishing the B strains in quadrivalent influenza vaccines.
Copyright ? 2017. Published by Elsevier B.V.


[h=4]KEYWORDS:[/h] Antibody-free strain identity; B strain separation; Hemagglutinin content; Quadrivalent influenza vaccines (QIV); Reversed-phased high-Performance liquid chromatography (RP-HPLC)

PMID: 29122283 DOI: 10.1016/j.chroma.2017.10.041
 
Back
Top Bottom